+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gastrointestinal Agents Market - Global Forecast 2026-2032- Product Image
Gastrointestinal Agents Market - Global Forecast 2026-2032- Product Image
New

Gastrointestinal Agents Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 180 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5977939
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The gastrointestinal agents market is responding to evolving clinical standards, shifting patient expectations, and new operational challenges, presenting both complexity and opportunity for healthcare stakeholders and product suppliers.

Market Snapshot: Gastrointestinal Agents Market

The Gastrointestinal Agents Market grew from USD 63.12 billion in 2025 to USD 66.15 billion in 2026 and is projected to reach USD 89.64 billion by 2032, marking a sustained CAGR of 5.13%. This growth reflects rising demand for effective therapies, diversification in product portfolios, and expanding access across regions.

Scope & Segmentation: Comprehensive Overview of Product and Market Structure

This report provides an in-depth segmentation of the gastrointestinal agents market, delineating critical factors that define both commercial and clinical dynamics:

  • Therapeutic Classes: Includes antacids (aluminum hydroxide, calcium carbonate, combinations, magnesium hydroxide, sodium bicarbonate), anti-diarrheals (adsorbents such as bismuth subsalicylate, kaolin pectin, and opioid derivatives like diphenoxylate atropine, loperamide), anti-emetics (dopamine antagonists, NK1 receptor antagonists, serotonin receptor antagonists—examples: metoclopramide, ondansetron, prochlorperazine, aprepitant, granisetron, fosaprepitant, palonosetron), H2 receptor antagonists (cimetidine, famotidine, nizatidine, ranitidine), laxatives (bulk-forming: methylcellulose, polycarbophil, psyllium; osmotic: lactulose, polyethylene glycol, sorbitol; lubricant, stimulant, stool softeners), probiotics and prebiotics (prebiotics: fructooligosaccharides, inulin; probiotics: bifidobacterium, lactobacillus, saccharomyces boulardii), and proton pump inhibitors (esomeprazole, lansoprazole, omeprazole, pantoprazole, rabeprazole).
  • Routes of Administration: Oral (capsule, liquid syrup, powder, tablet), intravenous (bolus injection, infusion), intramuscular, topical (creams, gels, suppositories).
  • Distribution Channels: Hospital pharmacies, online pharmacies, and retail pharmacies, each supporting unique procurement and supply chain dynamics.
  • Regions: Americas, Europe Middle East & Africa, Asia-Pacific—each region features distinct regulatory and procurement patterns, supply chain logistics, and end-user behaviors shaping product uptake and innovation.

Technology Adoption: Integration of digital diagnostics, adherence monitoring, and personalized formulations for chronic disease management is accelerating, enhancing therapy effectiveness and patient experience.

Key Takeaways: Strategic Insights from the Gastrointestinal Agents Market

  • Clinical priorities now emphasize long-term patient outcomes and experience in both outpatient and inpatient environments, influencing prescribing and purchasing patterns.
  • Manufacturers are incorporating advanced formulation and delivery mechanisms such as patient-friendly oral dosage forms and extended-release options to improve adherence and therapeutic persistence.
  • Regional differences in regulatory frameworks and procurement practices demand flexible commercialization, local regulatory expertise, and tailored partnerships to optimize market access and compliance.
  • Collaboration across supply chain partners, including contract development and manufacturing organizations, strengthens operational agility, quality assurance, and rapid response capabilities.
  • Digital integration is reshaping monitoring, evidence generation, and payer engagement, supporting outcome-based care models and product differentiation.
  • Scale-oriented companies maintain competitiveness through strategic manufacturing footprint and channel relationships, enabling broad access and robust price positioning within both established and emerging markets.

Tariff Impact: United States 2025 Measures

Recent U.S. tariff measures enacted in 2025 prompted manufacturers to reassess sourcing and diversify supply chains for active pharmaceutical ingredients. These changes led to short-term procurement shifts and encouraged domestic manufacturing investments. Downstream, payers and formulary decision-makers adjusted contract structures to account for volatility and risk, while clinicians experienced some changes in product selection based on availability.

Methodology & Data Sources

This analysis utilizes a mixed-methods approach encompassing qualitative stakeholder interviews and quantitative secondary data review. The methodology triangulates insights across procurement leaders, clinicians, manufacturing specialists, and public filings. Analysis includes scenario-based assessments and cross-validation for data reliability and transparency.

Why This Report Matters

  • Delivers actionable segmentation intelligence for evidence-based product positioning, enabling targeted commercialization and effective clinical adoption.
  • Equips senior leaders to proactively address regulatory, supply chain, and competitive pressures by aligning R&D, manufacturing capacity, and go-to-market strategies.
  • Facilitates strategic planning through scenario analysis, providing robust recommendations for supply chain resilience and payer-focused evidence generation.

Conclusion

Senior decision-makers gain a clear path to align innovation, operational resilience, and evidence with evolving clinical and commercial imperatives. Strategic adoption of these insights enables market differentiation and supports superior patient outcomes in the gastrointestinal agents sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Gastrointestinal Agents Market, by Product Type
8.1. Antacids
8.1.1. Aluminum Hydroxide
8.1.2. Calcium Carbonate
8.1.3. Combination Formulations
8.1.4. Magnesium Hydroxide
8.1.5. Sodium Bicarbonate
8.2. Anti Diarrheals
8.2.1. Adsorbents
8.2.1.1. Bismuth Subsalicylate
8.2.1.2. Kaolin Pectin
8.2.2. Opioid Derivatives
8.2.2.1. Diphenoxylate Atropine
8.2.2.2. Loperamide
8.3. Anti Emetics
8.3.1. Dopamine Antagonists
8.3.1.1. Metoclopramide
8.3.1.2. Prochlorperazine
8.3.2. NK1 Receptor Antagonists
8.3.2.1. Aprepitant
8.3.2.2. Fosaprepitant
8.3.3. Serotonin Receptor Antagonists
8.3.3.1. Granisetron
8.3.3.2. Ondansetron
8.3.3.3. Palonosetron
8.4. H2 Receptor Antagonists
8.4.1. Cimetidine
8.4.2. Famotidine
8.4.3. Nizatidine
8.4.4. Ranitidine
8.5. Laxatives
8.5.1. Bulk Forming
8.5.1.1. Methylcellulose
8.5.1.2. Polycarbophil
8.5.1.3. Psyllium
8.5.2. Lubricant
8.5.3. Osmotic
8.5.3.1. Lactulose
8.5.3.2. Polyethylene Glycol
8.5.3.3. Sorbitol
8.5.4. Stimulant
8.5.5. Stool Softeners
8.6. Probiotics & Prebiotics
8.6.1. Prebiotics
8.6.1.1. Fructooligosaccharides
8.6.1.2. Inulin
8.6.2. Probiotics
8.6.2.1. Bifidobacterium
8.6.2.2. Lactobacillus
8.6.2.3. Saccharomyces Boulardii
8.7. Proton Pump Inhibitors
8.7.1. Esomeprazole
8.7.2. Lansoprazole
8.7.3. Omeprazole
8.7.4. Pantoprazole
8.7.5. Rabeprazole
9. Gastrointestinal Agents Market, by Route Of Administration
9.1. Intramuscular
9.2. Intravenous
9.2.1. Bolus Injection
9.2.2. Infusion
9.3. Oral
9.3.1. Capsule
9.3.2. Liquid Syrup
9.3.3. Powder
9.3.4. Tablet
9.4. Topical
9.4.1. Creams
9.4.2. Gels
9.4.3. Suppositories
10. Gastrointestinal Agents Market, by Distribution Channel
10.1. Hospital Pharmacy
10.2. Online Pharmacy
10.3. Retail Pharmacy
11. Gastrointestinal Agents Market, by Region
11.1. Americas
11.1.1. North America
11.1.2. Latin America
11.2. Europe, Middle East & Africa
11.2.1. Europe
11.2.2. Middle East
11.2.3. Africa
11.3. Asia-Pacific
12. Gastrointestinal Agents Market, by Group
12.1. ASEAN
12.2. GCC
12.3. European Union
12.4. BRICS
12.5. G7
12.6. NATO
13. Gastrointestinal Agents Market, by Country
13.1. United States
13.2. Canada
13.3. Mexico
13.4. Brazil
13.5. United Kingdom
13.6. Germany
13.7. France
13.8. Russia
13.9. Italy
13.10. Spain
13.11. China
13.12. India
13.13. Japan
13.14. Australia
13.15. South Korea
14. United States Gastrointestinal Agents Market
15. China Gastrointestinal Agents Market
16. Competitive Landscape
16.1. Market Concentration Analysis, 2025
16.1.1. Concentration Ratio (CR)
16.1.2. Herfindahl Hirschman Index (HHI)
16.2. Recent Developments & Impact Analysis, 2025
16.3. Product Portfolio Analysis, 2025
16.4. Benchmarking Analysis, 2025
16.5. Abbott Laboratories
16.6. American Health
16.7. Amway Corporation
16.8. Archer-Daniels-Midland Company
16.9. ARKOPHARMA Laboratories, Company Limited
16.10. Bayer AG
16.11. Biomedical Research Laboratories, LLC
16.12. DuPont de Nemours, Inc.
16.13. Dymatize Enterprises LLC
16.14. FANCL Corporation
16.15. Glanbia PLC
16.16. GlaxoSmithKline PLC
16.17. Herbalife Nutrition Ltd.
16.18. Himalaya Wellness Company
16.19. Nature’s Sunshine Products, Inc.
16.20. Nestlé S.A
16.21. Nutraceutical International Corporation
16.22. NutraScience Labs
16.23. Otsuka Holdings Co. Ltd.
16.24. Pfizer Inc.
16.25. Pragati Biocare Pvt. Ltd.,
16.26. Procter & Gamble Health Limited
16.27. Pure Encapsulations, LLC.
16.28. Sabinsa Corporation
16.29. Sanofi S.A.
List of Figures
FIGURE 1. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL GASTROINTESTINAL AGENTS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL GASTROINTESTINAL AGENTS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 11. CHINA GASTROINTESTINAL AGENTS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTACIDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTACIDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTACIDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTACIDS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ALUMINUM HYDROXIDE, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ALUMINUM HYDROXIDE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ALUMINUM HYDROXIDE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY CALCIUM CARBONATE, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY CALCIUM CARBONATE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY CALCIUM CARBONATE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY COMBINATION FORMULATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY COMBINATION FORMULATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY COMBINATION FORMULATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY MAGNESIUM HYDROXIDE, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY MAGNESIUM HYDROXIDE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY MAGNESIUM HYDROXIDE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY SODIUM BICARBONATE, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY SODIUM BICARBONATE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY SODIUM BICARBONATE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTI DIARRHEALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTI DIARRHEALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTI DIARRHEALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTI DIARRHEALS, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ADSORBENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ADSORBENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ADSORBENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ADSORBENTS, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY BISMUTH SUBSALICYLATE, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY BISMUTH SUBSALICYLATE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY BISMUTH SUBSALICYLATE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY KAOLIN PECTIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY KAOLIN PECTIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY KAOLIN PECTIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY OPIOID DERIVATIVES, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY OPIOID DERIVATIVES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY OPIOID DERIVATIVES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY OPIOID DERIVATIVES, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DIPHENOXYLATE ATROPINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DIPHENOXYLATE ATROPINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DIPHENOXYLATE ATROPINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY LOPERAMIDE, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY LOPERAMIDE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY LOPERAMIDE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTI EMETICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTI EMETICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTI EMETICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTI EMETICS, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DOPAMINE ANTAGONISTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DOPAMINE ANTAGONISTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DOPAMINE ANTAGONISTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DOPAMINE ANTAGONISTS, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY METOCLOPRAMIDE, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY METOCLOPRAMIDE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY METOCLOPRAMIDE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PROCHLORPERAZINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PROCHLORPERAZINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PROCHLORPERAZINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY NK1 RECEPTOR ANTAGONISTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY NK1 RECEPTOR ANTAGONISTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY NK1 RECEPTOR ANTAGONISTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY NK1 RECEPTOR ANTAGONISTS, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY APREPITANT, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY APREPITANT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY APREPITANT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY FOSAPREPITANT, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY FOSAPREPITANT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY FOSAPREPITANT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY SEROTONIN RECEPTOR ANTAGONISTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY SEROTONIN RECEPTOR ANTAGONISTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY SEROTONIN RECEPTOR ANTAGONISTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY SEROTONIN RECEPTOR ANTAGONISTS, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY GRANISETRON, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY GRANISETRON, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY GRANISETRON, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ONDANSETRON, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ONDANSETRON, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ONDANSETRON, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PALONOSETRON, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PALONOSETRON, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PALONOSETRON, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY H2 RECEPTOR ANTAGONISTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY H2 RECEPTOR ANTAGONISTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY H2 RECEPTOR ANTAGONISTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY H2 RECEPTOR ANTAGONISTS, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY CIMETIDINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY CIMETIDINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY CIMETIDINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY FAMOTIDINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY FAMOTIDINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY FAMOTIDINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY NIZATIDINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY NIZATIDINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY NIZATIDINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY RANITIDINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY RANITIDINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY RANITIDINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY LAXATIVES, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY LAXATIVES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY LAXATIVES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY LAXATIVES, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY BULK FORMING, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY BULK FORMING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY BULK FORMING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY BULK FORMING, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY METHYLCELLULOSE, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY METHYLCELLULOSE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY METHYLCELLULOSE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY POLYCARBOPHIL, BY REGION, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY POLYCARBOPHIL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY POLYCARBOPHIL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PSYLLIUM, BY REGION, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PSYLLIUM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PSYLLIUM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY LUBRICANT, BY REGION, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY LUBRICANT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY LUBRICANT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY OSMOTIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY OSMOTIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY OSMOTIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY OSMOTIC, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY LACTULOSE, BY REGION, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY LACTULOSE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY LACTULOSE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY POLYETHYLENE GLYCOL, BY REGION, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY POLYETHYLENE GLYCOL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY POLYETHYLENE GLYCOL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY SORBITOL, BY REGION, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY SORBITOL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY SORBITOL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY STIMULANT, BY REGION, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY STIMULANT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY STIMULANT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY STOOL SOFTENERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY STOOL SOFTENERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY STOOL SOFTENERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PROBIOTICS & PREBIOTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PROBIOTICS & PREBIOTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PROBIOTICS & PREBIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PROBIOTICS & PREBIOTICS, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PREBIOTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PREBIOTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PREBIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PREBIOTICS, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY FRUCTOOLIGOSACCHARIDES, BY REGION, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY FRUCTOOLIGOSACCHARIDES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY FRUCTOOLIGOSACCHARIDES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY INULIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY INULIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 151. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY INULIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PROBIOTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PROBIOTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 154. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PROBIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 155. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
TABLE 156. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY BIFIDOBACTERIUM, BY REGION, 2018-2032 (USD MILLION)
TABLE 157. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY BIFIDOBACTERIUM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY BIFIDOBACTERIUM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 159. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY LACTOBACILLUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 160. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY LACTOBACILLUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY LACTOBACILLUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 162. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY SACCHAROMYCES BOULARDII, BY REGION, 2018-2032 (USD MILLION)
TABLE 163. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY SACCHAROMYCES BOULARDII, BY GROUP, 2018-2032 (USD MILLION)
TABLE 164. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY SACCHAROMYCES BOULARDII, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 165. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PROTON PUMP INHIBITORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 166. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PROTON PUMP INHIBITORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 167. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PROTON PUMP INHIBITORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 168. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PROTON PUMP INHIBITORS, 2018-2032 (USD MILLION)
TABLE 169. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ESOMEPRAZOLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 170. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ESOMEPRAZOLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 171. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ESOMEPRAZOLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 172. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY LANSOPRAZOLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 173. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY LANSOPRAZOLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 174. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY LANSOPRAZOLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 175. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY OMEPRAZOLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 176. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY OMEPRAZOLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 177. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY OMEPRAZOLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 178. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PANTOPRAZOLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 179. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PANTOPRAZOLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 180. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PANTOPRAZOLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 181. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY RABEPRAZOLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 182. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY RABEPRAZOLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 183. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY RABEPRAZOLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 184. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 185. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 186. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY INTRAMUSCULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 187. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY INTRAMUSCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 188. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 189. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 190. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 191. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 192. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY BOLUS INJECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 193. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY BOLUS INJECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 194. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY BOLUS INJECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 195. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY INFUSION, BY REGION, 2018-2032 (USD MILLION)
TABLE 196. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY INFUSION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 197. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY INFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 198. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 199. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 200. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 201. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 202. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY CAPSULE, BY REGION, 2018-2032 (USD MILLION)
TABLE 203. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY CAPSULE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 204. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY CAPSULE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 205. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY LIQUID SYRUP, BY REGION, 2018-2032 (USD MILLION)
TABLE 206. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY LIQUID SYRUP, BY GROUP, 2018-2032 (USD MILLION)
TABLE 207. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY LIQUID SYRUP, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 208. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
TABLE 209. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 210. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 211. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY TABLET, BY REGION, 2018-2032 (USD MILLION)
TABLE 212. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY TABLET, BY GROUP, 2018-2032 (USD MILLION)
TABLE 213. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY TABLET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 214. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 215. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY TOPICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 216. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY TOPICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 217. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 218. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY CREAMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 219. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY CREAMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 220. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY CREAMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 221. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY GELS, BY REGION, 2018-2032 (USD MILLION)
TABLE 222. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY GELS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 223. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY GELS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 224. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY SUPPOSITORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 225. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY SUPPOSITORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 226. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY SUPPOSITORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 227. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 228. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 229. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 230. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 231. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 232. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 233. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 234. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 235. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 236. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 237. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 238. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 239. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 240. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTACIDS, 2018-2032 (USD MILLION)
TABLE 241. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTI DIARRHEALS, 2018-2032 (USD MILLION)
TABLE 242. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY ADSORBENTS, 2018-2032 (USD MILLION)
TABLE 243. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY OPIOID DERIVATIVES, 2018-2032 (USD MILLION)
TABLE 244. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTI EMETICS, 2018-2032 (USD MILLION)
TABLE 245. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY DOPAMINE ANTAGONISTS, 2018-2032 (USD MILLION)
TABLE 246. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY NK1 RECEPTOR ANTAGONISTS, 2018-2032 (USD MILLION)
TABLE 247. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY SEROTONIN RECEPTOR ANTAGONISTS, 2018-2032 (USD MILLION)
TABLE 248. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY H2 RECEPTOR ANTAGONISTS, 2018-2032 (USD MILLION)
TABLE 249. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY LAXATIVES, 2018-2032 (USD MILLION)
TABLE 250. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY BULK FORMING, 2018-2032 (USD MILLION)
TABLE 251. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY OSMOTIC, 2018-2032 (USD MILLION)
TABLE 252. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY PROBIOTICS & PREBIOTICS, 2018-2032 (USD MILLION)
TABLE 253. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY PREBIOTICS, 2018-2032 (USD MILLION)
TABLE 254. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
TABLE 255. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY PROTON PUMP INHIBITORS, 2018-2032 (USD MILLION)
TABLE 256. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 257. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 258. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 259. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 260. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 261. NORTH AMERICA GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 262. NORTH AMERICA GASTROINTESTINAL AGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 263. NORTH AMERICA GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTACIDS, 2018-2032 (USD MILLION)
TABLE 264. NORTH AMERICA GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTI DIARRHEALS, 2018-2032 (USD MILLION)
TABLE 265. NORTH AMERICA GASTROINTESTINAL AGENTS MARKET SIZE, BY ADSORBENTS, 2018-2032 (USD MILLION)
TABLE 266. NORTH AMERICA GASTROINTESTINAL AGENTS MARKET SIZE, BY OPIOID DERIVATIVES, 2018-2032 (USD MILLION)
TABLE 267. NORTH AMERICA GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTI EMETICS, 2018-2032 (USD MILLION)
TABLE 268. NORTH AMERICA GASTROINTESTINAL AGENTS MARKET SIZE, BY DOPAMINE ANTAGONISTS, 2018-2032 (USD MILLION)
TABLE 269. NORTH AMERICA GASTROINTESTINAL AGENTS MARKET SIZE, BY NK1 RECEPTOR ANTAGONISTS, 2018-2032 (USD MILLION)
TABLE 270. NORTH AMERICA GASTROINTESTINAL AGENTS MARKET SIZE, BY SEROTONIN RECEPTOR ANTAGONISTS, 2018-2032 (USD MILLION)
TABLE 271. NORTH AMERICA GASTROINTESTINAL AGENTS MARKET SIZE, BY H2 RECEPTOR ANTAGONISTS, 2018-2032 (USD MILLION)
TABLE 272. NORTH AMERICA GASTROINTESTINAL AGENTS MARKET SIZE, BY LAXATIVES, 2018-2032 (USD MILLION)
TABLE 273. NORTH AMERICA GASTROINTESTINAL AGENTS MARKET SIZE, BY BULK FORMING, 2018-2032 (USD MILLION)
TABLE 274. NORTH AMERICA GASTROINTESTINAL AGENTS MARKET SIZE, BY OSMOTIC, 2018-2032 (USD MILLION)
TABLE 275. NORTH AMERICA GASTROINTESTINAL AGENTS MARKET SIZE, BY PROBIOTICS & PREBIOTICS, 2018-2032 (USD MILLION)
TABLE 276. NORTH AMERICA GASTROINTESTINAL AGENTS MARKET SIZE, BY PREBIOTICS, 2018-2032 (USD MILLION)
TABLE 277. NORTH AMERICA GASTROINTESTINAL AGENTS MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
TABLE 278. NORTH AMERICA GASTROINTESTINAL AGENTS MARKET SIZE, BY PROTON PUMP INHIBITORS, 2018-2032 (USD MILLION)
TABLE 279. NORTH AMERICA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 280. NORTH AMERICA GASTROINTESTINAL AGENTS MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 281. NORTH AMERICA GASTROINTESTINAL AGENTS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 282. NORTH AMERICA GASTROINTESTINAL AGENTS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 283. NORTH AMERICA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 284. LATIN AMERICA GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 285. LATIN AMERICA GASTROINTESTINAL AGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 286. LATIN AMERICA GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTACIDS, 2018-2032 (USD MILLION)
TABLE 287. LATIN AMERICA GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTI DIARRHEALS, 2018-2032 (USD MILLION)
TABLE 288. LATIN AMERICA GASTROINTESTINAL AGENTS MARKET SIZE, BY ADSORBENTS, 2018-2032 (USD MILLION)
TABLE 289. LATIN AMERICA GASTROINTESTINAL AGENTS MARKET SIZE, BY OPIOID DERIVATIVES, 2018-2032 (USD MILLION)
TABLE 290. LATIN AMERICA GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTI EMETICS, 2018-2032 (USD MILLION)
TABLE 291. LATIN AMERICA GASTROINTESTINAL AGENTS MARKET SIZE, BY DOPAMINE ANTAGONISTS, 2018-2032 (USD MILLION)
TABLE 292. LATIN AMERICA GASTROINTESTINAL AGENTS MARKET SIZE, BY NK1 RECEPTOR ANTAGONISTS, 2018-2032 (USD MILLION)
TABLE 293. LATIN AMERICA GASTROINTESTINAL AGENTS MARKET SIZE, BY SEROTONIN RECEPTOR ANTAGONISTS, 2018-2032 (USD MILLION)
TABLE 294. LATIN AMERICA GASTROINTESTINAL AGENTS MARKET SIZE, BY H2 RECEPTOR ANTAGONISTS, 2018-2032 (USD MILLION)
TABLE 295. LATIN AMERICA GASTROINTESTINAL AGENTS MARKET SIZE, BY LAXATIVES, 2018-2032 (USD MILLION)
TABLE 296. LATIN AMERICA GASTROINTESTINAL AGENTS MARKET SIZE, BY BULK FORMING, 2018-2032 (USD MILLION)
TABLE 297. LATIN AMERICA GASTROINTESTINAL AGENTS MARKET SIZE, BY OSMOTIC, 2018-2032 (USD MILLION)
TABLE 298. LATIN AMERICA GASTROINTESTINAL AGENTS MARKET SIZE, BY PROBIOTICS & PREBIOTICS, 2018-2032 (USD MILLION)
TABLE 299. LATIN AMERICA GASTROINTESTINAL AGENTS MARKET SIZE, BY PREBIOTICS, 2018-2032 (USD MILLION)
TABLE 300. LATIN AMERICA GASTROINTESTINAL AGENTS MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
TABLE 301. LATIN AMERICA GASTROINTESTINAL AGENTS MARKET SIZE, BY PROTON PUMP INHIBITORS, 2018-2032 (USD MILLION)
TABLE 302. LATIN AMERICA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 303. LATIN AMERICA GASTROINTESTINAL AGENTS MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 304. LATIN AMERICA GASTROINTESTINAL AGENTS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 305. LATIN AMERICA GASTROINTESTINAL AGENTS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 306. LATIN AMERICA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 307. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 308. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 309. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINA

Companies Mentioned

The key companies profiled in this Gastrointestinal Agents market report include:
  • Abbott Laboratories
  • American Health
  • Amway Corporation
  • Archer-Daniels-Midland Company
  • ARKOPHARMA Laboratories, Company Limited
  • Bayer AG
  • Biomedical Research Laboratories, LLC
  • DuPont de Nemours, Inc.
  • Dymatize Enterprises LLC
  • FANCL Corporation
  • Glanbia PLC
  • GlaxoSmithKline PLC
  • Herbalife Nutrition Ltd.
  • Himalaya Wellness Company
  • Nature’s Sunshine Products, Inc.
  • Nestlé S.A
  • Nutraceutical International Corporation
  • NutraScience Labs
  • Otsuka Holdings Co. Ltd.
  • Pfizer Inc.
  • Pragati Biocare Pvt. Ltd.,
  • Procter & Gamble Health Limited
  • Pure Encapsulations, LLC.
  • Sabinsa Corporation
  • Sanofi S.A.

Table Information

Report AttributeDetails
No. of Pages180
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 66.15 Billion
Forecasted Market Value ( USD ) by 2032 $ 89.64 Billion
Compound Annual Growth Rate5.1%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Gastric Antisecretory Drug Market Report 2025 - Product Image

Gastric Antisecretory Drug Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Gastrointestinal Therapeutics Market Report 2025 - Product Image

Gastrointestinal Therapeutics Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Peptic Ulcer Drugs Market - Global Forecast 2026-2032 - Product Image

Peptic Ulcer Drugs Market - Global Forecast 2026-2032

  • Report
  • 181 Pages
  • Global
From
Gastrointestinal Diseases Therapeutics Market - Global Forecast 2026-2032 - Product Image

Gastrointestinal Diseases Therapeutics Market - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From
Constipation Treatment Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Constipation Treatment Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From

About the Gastrointestinal Agent Market

The Gastrointestinal Agent market is a subset of the Gastrointestinal Drugs market, which includes drugs used to treat diseases and disorders of the digestive system. These agents are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and antibiotics. Other agents, such as probiotics, are also used to treat gastrointestinal disorders. The Gastrointestinal Agent market is highly competitive, with many companies offering a variety of products. Major players in the market include Pfizer, GlaxoSmithKline, Merck, AstraZeneca, and Novartis. Other companies, such as AbbVie, Allergan, and Takeda, also offer products in this market. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.